Endoscopy Clinical Trial
Official title:
A Phase IIa, Randomized, Controlled, Double-Blind, Dose-Finding Study Evaluating the Safety and Pharmacodynamics of CNS 7056 in Patients Undergoing Diagnostic Upper GI Endoscopy
The purpose of this study was to assess the safety and efficacy of CNS 7056 as a procedural sedative at three dose levels compared to midazolam during a diagnostic upper GI endoscopy.
This was a randomized, double-blind, parallel-group, dose-finding study assessing the safety
and efficacy of three dose levels of CNS 7056 compared with midazolam in patients undergoing
diagnostic upper GI endoscopy.
Patients who met all study entry criteria and completed screening procedures were randomly
assigned to 1 of 4 treatment groups: CNS 7056 0.10 mg/kg,0.15 mg/kg, or 0.20 mg/kg; or
midazolam 0.075 mg/kg. Patients received their assigned treatment administered as a single
intravenous injection by a syringe driver over 1 minute. The endoscopy started when a
Modified Observer's Assessment of Alertness/Sedation (MOAA/S) score of ≤3 has been reached,
but no earlier than 90 seconds after Time 0 (the start of study drug injection). Rescue with
sedative medication (midazolam 1-2 mg) was be permitted at the discretion of the
administering physician.
Efficacy assessments consisted of the MOAA/S scores, Aldrete scores, and drowsiness measures
using a Visual Analogue Scale (VAS). Cognitive function was assessed by the Hopkins Verbal
Learning Test-Revised™ (HVLT-R™) and memory for the procedure by the Brice Questionnaire.
Safety assessments included adverse events, physical examinations, vital signs, ECGs, pulse
oximetry measurements, clinical laboratory tests, and pain on injection using a VAS.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03298776 -
I-Scan a Novel Endoscopic Tool for the Macroscopic Identification of Mucosal Lesions
|
N/A | |
Completed |
NCT02887378 -
Protocol for Anatomopathologic Analysis of Biopsies Using Hot Clamps
|
N/A | |
Recruiting |
NCT01627171 -
Colonoscopy Preparation Optimization for INpatients- COIN Study
|
Phase 4 | |
Completed |
NCT02350933 -
Endoscopic Evaluation of the Paediatric Airway After Prior Prolonged (>24 h) Tracheal Intubation
|
N/A | |
Completed |
NCT00671177 -
Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique
|
N/A | |
Completed |
NCT06033729 -
Remifentanil Target Controlled Infusion Versus Standard of Care for Conscious Sedation During EBUS-TBNA
|
N/A | |
Withdrawn |
NCT04983498 -
Enhanced Recovery Pathway for Endoscopy
|
Phase 4 | |
Enrolling by invitation |
NCT04719117 -
Retrograde Cholangiopancreatography AI Assisted System Validation on Effectiveness and Safety
|
||
Completed |
NCT03369197 -
Nasal Continuous Positive Airway Pressure Versus Standard Care During Procedural Sedation for Gastrointestinal Endoscopy
|
N/A | |
Completed |
NCT04186390 -
Learning Small Bowel Capsule Endoscopy
|
||
Completed |
NCT02714699 -
Oral Hyoscine Butyl Bromide Versus Diclofenac Potassium Before Office Hysteroscopy
|
Phase 2/Phase 3 | |
Completed |
NCT00614159 -
Ketamine Compared to Propofol for Pediatric GI Endoscopy
|
N/A | |
Completed |
NCT04072328 -
Propofol vs. Midazolam With Propofol for Sedative Endoscopy in Patients With Previous Paradoxical Reaction to Midazolam
|
Phase 2 | |
Completed |
NCT04150237 -
Using Simulation to Ensure Basic Competence in Gastroscopy
|
||
Completed |
NCT03287687 -
Safety and Efficacy of CO2 for Endoscopy
|
Phase 4 | |
Not yet recruiting |
NCT03351790 -
Endoscopy Quality Study
|
N/A | |
Completed |
NCT04541667 -
Is End Tidal CO2 Level Elevation During Upper Endoscopy With CO2 Gas Insufflation Physiologically Significant
|
N/A | |
Active, not recruiting |
NCT06168682 -
Nasal CPAP - The Treatment IMpact on Oxygenation in High-risk Patients During Deep Sedation for Endoscopy
|
N/A | |
Recruiting |
NCT05479253 -
AI-assisted Endoscopy Report System In Improving Reporting Quality
|
N/A | |
Recruiting |
NCT04903444 -
Development and Validation of an Artificial Intelligence-based Biliary Stricture Navigation System in MRCP-based ERCP
|
N/A |